Bakersfield, CALIFORNIA3 Active Studies

Diabetic Retinopathy Clinical Trials in Bakersfield, CALIFORNIA

Find 3 actively recruiting diabetic retinopathy clinical trials in Bakersfield, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,772
Enrolling

Recruiting Diabetic Retinopathy Studies in Bakersfield

About Diabetic Retinopathy Clinical Trials in Bakersfield

Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.

There are currently 3 diabetic retinopathy clinical trials recruiting participants in Bakersfield, CALIFORNIA. These studies are seeking a combined 1,772 participants. Research is being sponsored by EyeBiotech Ltd., Hoffmann-La Roche, Boehringer Ingelheim. Clinical trial participation is free and participants receive study-related medical care at no cost.

Diabetic Retinopathy Clinical Trials in Bakersfield — FAQ

Are there diabetic retinopathy clinical trials in Bakersfield?

Yes, there are 3 diabetic retinopathy clinical trials currently recruiting in Bakersfield, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Bakersfield?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bakersfield research site will contact you about next steps.

Are clinical trials in Bakersfield free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bakersfield studies also compensate for your time and travel.

What diabetic retinopathy treatments are being tested?

The 3 active trials in Bakersfield are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.

Data updated March 2, 2026 from ClinicalTrials.gov